They're designed to: Confirm the weight loss and metabolic benefits seen in Phase 2 Identify rare side effects that smaller trials might have missed Demonstrate consistent results across diverse populations (age, sex, ethnicity, comorbidities) Build long-term safety data (cardiovascular outcomes, liver health, kidney function) Provide the evidence package the FDA needs to approve the drug Retatrutide's Phase 2 results were strong enough (up to 24.2% weight loss) that Eli Lilly moved it into a large Phase 3 program
Be sure to follow for monthly promos, Botox parties, before and afters, etc
Proteins and peptides which are useful for the treatment of various diseases in humans and animals are known
Zepbound, tirzepatides weight-loss twin, hits an even bigger wall
It is best to avoid food high in sugar such as soft drinks, alcohol, cakes, sweets, and processed food
/ SEND QUERY Express Shipments from New Zealand/Turkey/India 117-4B : of Novo Nordisk